Impact of MEK Inhibitor Therapy on Neurocognitive Functioning in NF1.
Walsh KS, Wolters PL, Widemann BC, Del Castillo A, Sady MD, Inker T, Roderick MC, Martin S, Toledo-Tamula MA, Struemph K, Paltin I, Collier V, Mullin K, Fisher MJ, Packer RJ.
Walsh KS, et al. Among authors: toledo tamula ma.
Neurol Genet. 2021 Aug 6;7(5):e616. doi: 10.1212/NXG.0000000000000616. eCollection 2021 Oct.
Neurol Genet. 2021.
PMID: 34377779
Free PMC article.